Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glecaprevir/Pibrentasvir in patients with chronic
HCV
genotype 3 infection: An integrated phase 2/3 analysis
Authors
Keywords
-
Journal
JOURNAL OF VIRAL HEPATITIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-11-13
DOI
10.1111/jvh.13038
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial
- (2018) David Wyles et al. HEPATOLOGY
- EASL Recommendations on Treatment of Hepatitis C 2018
- (2018) Jean-Michel Pawlotsky et al. JOURNAL OF HEPATOLOGY
- Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection
- (2018) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of hepatitis C with new fixed dose combinations
- (2017) Vincent Soriano et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials
- (2017) Ira M. Jacobson et al. GASTROENTEROLOGY
- Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
- (2017) Marc Bourlière et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+)
- (2016) Vincent Leroy et al. HEPATOLOGY
- Pharmacokinetics, Safety, and Tolerability of Next Generation Direct Acting Antivirals ABT-493 and ABT-530 in Subjects with Renal Impairment
- (2016) M.P. Kosloski et al. JOURNAL OF HEPATOLOGY
- A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin
- (2016) Tarik Asselah et al. PLoS One
- All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study
- (2015) David R. Nelson et al. HEPATOLOGY
- Natural prevalence of resistance-associated variants in hepatitis C virus NS5A in genotype 3a-infected people who inject drugs in Germany
- (2015) Andreas Walker et al. JOURNAL OF CLINICAL VIROLOGY
- Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data?
- (2015) Jason Grebely et al. JOURNAL OF HEPATOLOGY
- A phase 1, randomized, dose-ranging study of GS-5816, a once-daily NS5A inhibitor, in patients with genotype 1-4 hepatitis C virus
- (2015) E. Lawitz et al. JOURNAL OF VIRAL HEPATITIS
- Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
- (2015) Graham R. Foster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review article: HCV genotype 3 - the new treatment challenge
- (2014) J. Ampuero et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Global epidemiology and genotype distribution of the hepatitis C virus infection
- (2014) Erin Gower et al. JOURNAL OF HEPATOLOGY
- Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Natural prevalence of NS5A polymorphisms in subjects infected with hepatitis C virus genotype 3 and their effects on the antiviral activity of NS5A inhibitors
- (2013) Dennis Hernandez et al. JOURNAL OF CLINICAL VIROLOGY
- Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels
- (2013) Jason Grebely et al. JOURNAL OF INFECTIOUS DISEASES
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis
- (2011) G. Nkontchou et al. JOURNAL OF VIRAL HEPATITIS
- HCV genotype 3: An independent predictor of fibrosis progression in chronic hepatitis C
- (2009) Stella De Nicola et al. JOURNAL OF HEPATOLOGY
- Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C
- (2009) Pierre-Yves Bochud et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More